Evidence map›Paper›PMID 39301934›Full record

ArticleFuture medicinal chemistry2024

Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer.

Sandhya Chahal, Payal Rani, Rajvir Singh, Gaurav Joshi, Roshan Kumar, Parvin Kumar, Deepak Wadhwa, Devender Singh, Jayant Sindhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sandhya ChahalDepartment of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar, 125004, India.ORCID 0000-0002-0092-9659
Payal RaniDepartment of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar, 125004, India.ORCID 0000-0001-8055-0253
Rajvir SinghDepartment of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar, 125004, India.ORCID 0000-0002-2826-0205
Gaurav JoshiDepartment of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar, Dist. Garhwal, Uttarakhand, 246174, India.ORCID 0000-0002-7812-2871
Roshan KumarDepartment of Microbiology, Central University of Punjab, VPO, Gudha, 151401, Punjab.ORCID 0000-0001-6202-4479
Parvin KumarDepartment of Chemistry, Kurukshetra University, Kurukshetra, Haryana, 136119, India.ORCID 0000-0002-2635-6465
Deepak WadhwaDepartment of Chemistry, Chaudhary Bansi Lal University, Bhiwani, 127021, India.ORCID 0000-0002-3948-0414
Devender SinghDepartment of Chemistry, Maharshi Dayanand University, Rohtak, 124001, India.ORCID 0000-0002-2180-5049
Jayant SindhuDepartment of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar, 125004, India.ORCID 0000-0003-0207-0662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-AmylasesAntineoplastic AgentsCell ProliferationNaphthoquinonesAntioxidantsCell Line, TumorDiabetes MellitusDrug Screening Assays, AntitumorEnzyme InhibitorsHumansMolecular StructureNeoplasmsStructure-Activity Relationshipalpha-AmylasesAntineoplastic AgentsAntioxidantsEnzyme InhibitorsNaphthoquinonesanti-canceranti-oxidantbenzodiazepineshyperamylasemiamolecular dockingmulticomponent reactionα-amylase

Identifiers

PMID39301934
PMCPMC11622778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.